AcidicGreyMatter t1_j3gg0o2 wrote
Reply to comment by bobbi21 in A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. by glawgii
Okay so if I am wrong, correct me with the source of funding, because your comment doesn't correct me, it makes a baseless claim that I made it up, which my claim is not made up, you can look up the investors behind pharmazz yourself.
I have read through it and have not seen any mention of a specific university that provided the funding for this.
JonBoscoe t1_j3gm189 wrote
Troll alert
elhabito t1_j3h5j61 wrote
They gave you the source of the funding in the first two sentences.
Is this because you heard Donald Trump say hydroxy chloroquine 1,000 times during the pandemic? You should know he is not a doctor, a research candidate, or even a good businessman.
RatMannen t1_j3h8kgf wrote
They directly answered exactly those points. Try again. x
Jacko411 t1_j3hxu7g wrote
Just admit you don't kno what "conflict of interest" means.
[deleted] t1_j3gkylb wrote
[removed]
Viewing a single comment thread. View all comments